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E ndoscopic submucosal dissection (ESD) has emerged as the primary treatment option for early 
gastric neoplasms.  However,  approximately 3-11% of 
patients treated by this method develop post-proce-
dural aspiration pneumonia [1 , 2].  Although this com-
plication may occur more frequently than post-ESD 
bleeding and perforation [3],  its prevention has received 
less attention.
There have been studies indicating that higher age,  
male sex,  and long procedure time may increase the 
rate of post-ESD pneumonia [1 , 2].  Professional clean-
ing of the oral cavity by dental hygienists,  including 
cleaning of the dentures,  oral mucous membrane,  and 
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Endoscopic submucosal dissection (ESD) has become the first-line treatment for early gastric neoplasms; how-
ever,  a subset of patients treated by this method develop aspiration pneumonia.  We conducted a comprehen-
sive prospective analysis of the factors contributing to post-ESD aspiration pneumonia in early gastric neo-
plasms in this study,  with special focus on whether pre-treatment oral care can prevent aspiration pneumonia.  
Sixty-one patients who underwent ESD for gastric neoplasms were randomly assigned to the oral care or control 
groups.  ESD was performed under deep sedation.  Of 60 patients whose data were available for analysis,  
5 (8.3%) experienced pneumonia confirmed either by chest radiography or computed tomography.  Although no 
difference in the rate of pneumonia was found between the control and oral care groups,  the post-oral care bac-
teria count was significantly higher in the saliva of patients who developed pneumonia compared to those with-
out pneumonia.  In addition,  the presence of vascular brain diseases and the dose of meperidine were also sig-
nificantly associated with the occurrence of pneumonia.  These results suggest that the number of oral bacteria 
as well as pre-existing vascular brain diseases and high-dose narcotics can affect the incidence of post-ESD 
pneumonia.
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tongue,  has been shown to reduce the levels of oropha-
ryngeal microorganisms and decrease the incidence of 
pneumonia in various groups of patients,  including 
neonates in intensive care units and elderly in nursing 
homes [4-6].  Professional oral care treatment prior to 
surgery requiring general anesthesia was also found to 
be effective in reducing the rates of post-operative 
pneumonia [7 , 8].  This randomized control study 
aimed to analyze the factors contributing to post-ESD 
aspiration pneumonia,  with special focus on the poten-
tial prophylactic effect of pre-procedural professional 
oral care.
Materials and Methods
Patients and study design. The present study 
included the patients who underwent upper ESD for 
early gastric carcinoma or adenoma at Nagasaki 
University Hospital and Isahaya General Hospital 
between December 2016 and December 2019.  The 
study was approved by the Ethics Committee of the 
Nagasaki University (16092604),  UMIN000024259.  
Patients under 20 years of age and those not able to give 
informed consent were excluded from the study.  All 
patients provided written informed consent after 
receiving sufficient explanation of the study aims and 
methods.
The patients were randomized to the oral care group 
or control group using a sealed opaque envelope to con-
ceal the random allocation sequence until interventions 
were assigned [9].  Patients from the oral care group 
were instructed to visit a dental care unit to receive pro-
fessional oral care (cleaning of teeth,  dentures,  oral 
mucous membrane,  and tongue) before admission for 
the ESD procedure.  A uniform oral care protocol was 
devised and was shared with the dentists of the two 
institutions in order to ensure uniformity.  The number 
of oral bacteria was measured before and after the oral 
care.  The bacteria count was expressed as colony form-
ing units (CFU)/ml.  Patients in the control group did 
not receive oral care.
Before and after the procedure,  body temperature,  
peripheral blood oxygen saturation (SpO2),  and inflam-
matory markers,  including the C-reactive protein 
(CRP) level,  were examined.  Thoracic radiography was 
performed when the patient had one or more of the 
following conditions: respiratory symptoms,  such as 
cough or sputum,  fever > 37.5°C,  SpO2 < 94% or SpO2 
drop > 3% compared to the pre-procedural level,  posi-
tive lung murmur,  or CRP level > 2 mg/l [10 , 11].  If 
chest radiograph showed signs of consolidation,  pneu-
monia was diagnosed.  If radiography was inconclusive,  
computed tomography (CT) was performed to exclude 
pneumonia.  Age,  sex,  underlying diseases,  smoking,  
procedure time,  history of stomach surgery,  size of the 
lesion,  and sedation medications were all considered to 
be potential risk factors for the development of post-
ESD pneumonia.  Thus,  this information was also gath-
ered and was analyzed to determine the association with 
post-ESD pneumonia.  
Statistics. Statistical analysis was performed by a 
statistician (HK).  The statistical significance of differ-
ences in quantitative parameters between the two 
groups (oral care vs.  control or pneumonia vs.  no 
pneumonia) was assessed by Wilcoxon’s test.  Fisher’s 
exact test was used to detect the statistical difference 
between 2 nominal variables.  Differences in the value 
between the 2 time periods for each patient were 
assessed using the paired Wilcoxon test.  Cochran-
Armitage test was employed to assess the relationship 
between the dose of meperidine and the rate of pneu-
monia.  A p value < 0.05 was considered statistically 
significant.  All calculations were performed using SAS 
software (version 9.3; SAS Institute,  Cary,  NC,  USA).
Results
Only 61 of 302 preplanned patients were enrolled,  
and thus the trial had to be terminated due to poor 
accrual.  The 61 patients were randomized to the oral 
care group (n = 33) or control group (n = 28) using a 
sealed opaque envelope to conceal the random alloca-
tion sequence until interventions were assigned (Fig. 1).  
Among the 61 patients,  1 patient who was randomized 
to the oral care group but did not complete the ESD 
procedure due to fibrosis and the subsequent require-
ment of surgical resection was excluded.  Thus,  the 
remaining 60 patients were subjected to further analysis 
(Fig. 1).  The mean age of the enrolled patients was 
73.5 ± 7.9 years.  Fifty were men and 10 were women.  
No significant differences in age,  sex,  or other underly-
ing conditions were detected between the control and 
oral care groups (Table 1).  Depending on the patient’s 
oral hygiene,  the number of visits ranged from 1 to 4.  It 
was not possible to determine the oral bacterial count of 
1 of the 33 patients who underwent oral care,  due to 
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significant dryness of the oral mucosa.  The bacteria count 
of 28 patients decreased after oral care, while the bacte-
ria counts increased in 4 patients.  The overall bacterial 
count decreased significantly after oral care (median:  
15,000,000 CFU/ml before and 2,255,000 CFU/ml after 
oral care,  p < 0.001,  paired Wilcoxon test) (Fig. 2).
Among the 60 patients,  18 (30%) had respiratory 
symptoms or body temperature≥37.5°C,  and 10 (16.7%) 
had SpO2 < 94% and/or SpO2 drop > 3% compared to the 
pre-ESD value.  After examination by chest radiography 
and CT,  5 (8.3%) patients were diagnosed with post-ESD 
pneumonia.  Of them,  1 was diagnosed by chest radi-
ography,  while in the other 4 patients only CT could 
detect the pneumonia.  All patients with pneumonia 
received antibiotic therapy and were discharged after 
full recovery.  Among patients from the oral care group,  
4 (12.5%) developed pneumonia,  whereas in the con-
trol group,  1 (3.6%) patient developed pneumonia 
(Table 1).  Pneumonia rates were not statistically differ-
ent between the oral care and control groups (Table 1).  
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Fig. 1　 Design of the current study.
B
ac
te
ria
 c
ou
nt
 (
C
FU
/m
l)
120,000,000
100,000,000
80,000,000
60,000,000
40,000,000
20,000,000
0
Before After
Fig. 2　 Oral bacteria count before and after oral care.  Black lines 
and dotted gray lines indicate the patients who did and did not 
develop pneumonia,  respectively.  P<0.05,  before oral care vs.  
after oral care.  CFU: colony forming units.
Table 1　 Background and occurrence of pneumonia in included patients
Oral care
(n=32)
Control
(n=28) P value
Sex,  n
Male 27 25 0.71
Female 5 3
Age (years), mean±SD 72±1.12 76±9.11 0.32
History of gastric surgery,  n (%) 4 (12.5) 3 (11.7) 1
Respiratory disease,  n (%) 4 (12.5) 3 (11.7) 1
Cerebrovascular disease,  n (%) 4 (12.5) 0 0.12
Diabetes mellitus,  n (%) 8 (25.0) 8 (28.6) 0.79
Post -ESD pneumonia 4 (12.5) 1 (3.6) 0.36
Control group included patients who did not receive oral care
SD,  standard deviation;  ESD,  endoscopic submucosal dissection;  
Age differences between Oral care and control care groups were assessed by Wilcoxon test.  Fisherʼs exact test was used to detect the 
statistical difference between two nominal variables
Table 2 summarizes the background characteristics of 
patients with pneumonia.  Significant increases in WBC 
count and CRP level were detected in patients with 
pneumonia the day after ESD (Table 3).  The overall 
medical cost was significantly higher in patients who 
developed pneumonia compared to those who did not,  
whereas no significant difference in admission duration 
was found between the 2 groups (Table 3).
Among the 4 patients in the oral care group who 
developed pneumonia,  the bacteria count in saliva was 
decreased in 3 patients and increased in 1 patient after 
the oral care (Fig. 2).  Interestingly,  the bacteria count 
after the oral care was significantly higher in the 
patients who developed pneumonia than in those who 
did not (median: 7,550,000 vs.  2,980,577 CFU after 
oral care in the groups with and without pneumonia,  
respectively; p < 0.001,  Wilcoxon test) (Fig. 3).
Next,  we sought to identify factors that potentially 
contributed to the occurrence of post-ESD pneumonia.  
Although patients with pneumonia were all men,  male 
sex was not a statistically significant factor for pneumo-
nia occurrence (Table 4).  The presence of cerebrovas-
cular disease was significantly associated with the 
occurrence of pneumonia (p = 0.03),  whereas neither 
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Table 2　 Characteristics of patients who developed post-ESD pneumonia
Case Sex Age (years) Oral care
History of 
gastric  
surgery
Respiratory 
disease
Cerebrovascular 
disease
Diabetes 
mellitus
1 Male 70 + - - - -
2 Male 69 + - + + +
3 Male 87 - + - - -
4 Male 65 + - + + -
5 Male 85 + - - - -
“+” indicates the presence of the disease and “-” indicates absence of the disease.
Table 3　 Comparison patientsʼ characteristics between pneumonia and non-pneumonia groups
Pneumonia 
(n=5) 
No pneumonia 
(n=55) P value
CRP level (mg/l) 3.77±2.44 0.934±1.12 0.00005*
WBC count (/µl) 11,920±2,163 8,650±2,693 0.02*
Days of admission 14.8±4.96 11.7±5.57 0.22
Medical cost (yen) 831,312±197,676 622,980±128,083 0.002*
*P value<0.05 
Significance between the groups were assessed by assessed by Wilcoxonʼs test.  
Numbers indicate mean values±SD.  CRP,  C-reactive protein,  WBC,  white blood cell.
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Fig. 3　 Comparison of bacteria count after oral care in the patients 
according to the presence or absence of pneumonia.  p<0.05,  
pneumonia vs.  no pneumonia.  CFU,  colony forming units.
diabetes mellitus nor smoking status was associated with 
pneumonia occurrence (Table 4).  The incidence of 
underlying pulmonary diseases was higher in the pneu-
monia group (40% vs.  9.1%,  pneumonia vs.  non- 
pneumonia),  but the difference did not reach the level 
of statistical significance (p = 0.09) (Table 4).  Although 
the procedure time tended to be longer in the pneumo-
nia group,  the difference was not statistically different.
We then analyzed the medications used for sedation.  
When patients were divided into categories according to 
whether they received ≤70 mg,  71-105 mg,  106-140 mg,  
or ≥ 141 mg meperidine,  the incidences of pneumonia 
in these groups were 0% (0/9),  7.8% (1/13),  18.2% 
(2/11),  and 25.0% (2/8),  respectively,  revealing a sig-
nificant increase of pneumonia incidence with increas-
ing dose of meperidine (Table 5).  In contrast,  the use of 
pentazocine,  midazolam,  and diazepam were not sig-
nificantly different between the pneumonia and 
non-pneumonia groups.  
Discussion 
The current study showed that the presence of 
underlying cerebrovascular diseases and the drug used 
for sedation may have affected the incidence of post-
ESD pneumonia,  although the results did not fully 
clarify whether the impact of oral care affected the inci-
dence of pneumonia under deep-sedation conditions.  
The initial aim of the study was to determine 
whether oral care could prevent aspiration pneumonia.  
In 2015,  the post-ESD pneumonia rate was 10.0% at 
Nagasaki University Hospital.  Based on this fact,  we 
estimated that the pneumonia detection rate would be 
approximately 15.0% over the first year of the study 
period with increased chest X-ray and CT.  We also esti-
mated that oral care would reduce the pneumonia rate 
to approximately 4.0%.  Given these predictions,  we 
estimated that 302 cases would be needed to attain a 
statistical power of 80% and derive statistically relevant 
results.  The primary endpoint of this study was the rate 
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Table 4　 Potential factors related to pneumonia development
Pneumonia 
(n=5)
No pneumonia 
(n=55) P value
Sex,  n
Male 5 (100) 47 (85.5) 0.57
Female 0 (0.00) 8 (14.5)
Age (years),  mean±SD 75.2±10.1 73.4±7.6 0.93
History of gastric surgery,  n (%) 1 (20.0) 6 (11.3) 0.47
Respiratory disease,  n (%) 2 (40.0) 5 (9.09) 0.09
Cerebrovascular disease,  n (%) 2 (40.0) 2 (3.67) 0.03*
Diabetes mellitus,  n (%) 1 (20.0) 15 (27.3) 1.00
Presence of oral care,  n (%) 4 (80.0) 23 (41.8) 0.36
Procedure time (min),  mean±SD 206±222 135±70.7 0.09
*P value<0.05 
Age differences between Oral care and control care groups were assessed by Wilcoxon test.  Fisherʼs exact test was used to detect the 
statistical difference between two nominal variables.
Table 5　 Association between meperidine dose and rate of post-ESD pneumonia
Meperidine dose (mg)
≤70 71–105 106–140 ≥141
Pneumonia (n) - 9 12 9 6
+ 0 1 2 2
Rate of pneumonia 0.00% 7.80% 18.2% 25.0%
P=0.04,  Cochran-Armitage test
“+” indicates the presence of the disease and “-” indicates absence of the disease 
ESD,  endoscopic submucosal dissection
of post-ESD pneumonia.  However,  only 61 patients 
agreed to enroll.  Due to the low rate of case entry,  
enrollment was terminated at 3 years without further 
registration.  The number of patients was not sufficient to 
effectively determine whether oral care could influence 
the incidence of pneumonia after ESD.  The principle 
reason for refusal to participate was that the patients 
declined to visit the hospital multiple times for oral care,  
and the rate of such non-compliance was underestimated 
during the initial planning.  Therefore,  before applying 
a protocol of oral care for patients undergoing ESD at 
larger medical centers,  the problem of non-compliance 
must be addressed,  since patients visiting major medi-
cal centers often travel from remote areas and have 
underlying diseases that make multiple visits to the 
hospital difficult.  To overcome these issues,  more 
locally located dental clinics could offer comprehensive 
oral care in cooperation with the medical centers.  To 
address these issues,  another multi-center prospective 
study is being planned based on the current results.
There was no significant difference in pneumonia 
rate between the oral and non-oral care groups in this 
study.  However,  the bacteria count after oral care 
tended to be higher in those who developed pneumo-
nia.  Although additional studies are required,  supple-
mentary methods such as post-ESD oral care may 
ensure the optimal oral hygiene of patients.
Patients are not intubated in the case of deep sedation.  
Thus,  the ability to eliminate saliva from the airway,  e.g.,  
the extent of the gag reflex,  may also largely determine 
the amount of aspiration.  This study showed that pneu-
monia rates increased proportionally with meperidine 
dose.  Meperidine is a widely used narcotic analgesic in 
Japan and can be efficiently used alone or with other 
sedative drugs,  such as midazolam or other benzodiaz-
epines [8].  In our study,  although the dose of benzodi-
azepine did not affect the rate of pneumonia,  that of 
meperidine did.  Notably,  the majority of patients with 
pneumonia received more than 105 mg of meperidine.  
In addition,  25% of patients who received more than 
140 mg of meperidine presented with pneumonia.  
Previous research suggested a relationship between opi-
oid use and the incidence of aspiration pneumonia after 
upper gastrointestinal ESD [12].  Meperidine is known 
to have a relatively strong inhibitory effect on gag 
reflexes,  which may increase the risk of aspiration [13-
15].  Our results suggest that endoscopists should be 
cautious regarding the extended use of opioids,  espe-
cially meperidine [15 , 16].
Generally,  the dose of narcotics increases propor-
tionally with the resection time during ESD performed 
under deep sedation.  Akasaka et al.  [17] have reported 
that a procedure time of > 5 h was an independent risk 
factor for post-procedural aspiration pneumonia.  In 
another retrospective study,  a procedure time of > 2 h 
was reported to be an independent factor for aspiration 
pneumonia after ESD performed under deep sedation 
[12].
Together with the results reported in previous studies,  
our present findings raise the question of whether all 
upper gastrointestinal ESD procedures should be per-
formed under general anesthesia in order to avoid 
excessive use of narcotics and decrease the risk of aspi-
ration.  Indeed,  in a study comparing the impact of 
general anesthesia and deep sedation on pneumonia 
occurrence during esophageal ESD [2],  the rates of 
aspiration pneumonia were lower in the general anes-
thesia group,  although not significantly so [2].  Given 
the inherent risk and the high cost of the medicines,  the 
potential use of general anesthesia in ESD procedures 
will require further assessment.
 Age > 75 years and male sex have been reported to 
be independent risk factors of aspiration pneumonia 
after ESD performed under deep sedation [12].  Although 
this study did not show significant differences in age or 
sex between the pneumonia and non-pneumonia 
groups,  the absence of these relations may have been 
related to the relatively small number of subjects and the 
fact that 80% were men [12].  In this study,  consistent 
with the results of previous studies,  the presence of 
cerebrovascular disease was related to pneumonia 
occurrence [18].  Vascular brain disease is a known 
cause of dysphagia and aspiration [19]; thus,  these 
patients require special attention as a high-risk group 
for post-ESD pneumonia.  
In conclusion,  this study did not prove that oral care 
is effective to prevent ESD-related pneumonia in deep 
sedative states.  However,  our results did underscore 
that patients with underlying cerebrovascular diseases 
and those requiring higher doses of sedative drugs 
should be monitored carefully for the occurrence of 
respiratory complications.  
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